On March 21, Congress reached an agreement on the final six fiscal year 2024 (FY’24) appropriations bills. The package includes the Labor-HHS-Education, Defense, Financial Services, Homeland Security, Legislative Branch and State-Foreign Operations bills. The legislation is expected to pass the House and Senate and be signed into law by the President.
On March 21, Congress reached an agreement on the final six fiscal year 2024 (FY’24) appropriations bills. The package includes the Labor-HHS-Education, Defense, Financial Services, Homeland Security, Legislative Branch and State-Foreign Operations bills. The legislation is expected to pass the House and Senate and be signed into law by the President.
NCSD is pleased to report that—although it was a tough negotiation year—the agreement includes $174,310,000 for STD prevention at CDC, the same funding level as provided in FY’23. Language is also included that ensures that no PCHD grantee receives less funds than it did last year; and directs the CDC to continue to move the grant year forward by one month to provide for a more efficient expenditure of funds and improve grantee activities, with the intention that the grant year will be moved forward by at least one month each year for the next three years. It is NCSD’s goal ultimately to move the grant year to July to limit disruptions to the program caused by late appropriations.
Along with the funding levels outlined in the chart below, the final funding package provides instructions to the administration that will support STI prevention, including:
The chart below includes enacted funding from FY’21-FY’24, as well as the President’s Budget Request for FY’25, which was released last week.
| Final FY’21 Funding | Final FY’22 Funding | Final FY’23 Funding | Final FY’24 Funding | President’s FY’25 Budget Proposal | |
| CDC – National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Infections (STIs), and Tuberculosis Prevention | $1.314 b | $1.345 b | $1.391 b | $1.391 b | $1.391 b |
| CDC – Division of STD Prevention (DSTDP) | $161.8 m | $164.3 m | $174.3 m | $174.3 m | $174.3 m |
| CDC – Domestic HIV Prevention (DHP) | $755.6 m | $755.6 m | $755.6 m | $755.6 m | $755.6 m |
| CDC – Division of Adolescent and School Health (DASH) | $34.1 m | $36.1 m | $38.1 m | $38.1 m | $38.1 m |
| CDC – Division of Viral Hepatitis | $39.5 m | $41.5 m | $43 m | $43 m | $43 m |
| CDC – Division of Tuberculosis Elimination | $135 m | $135 m | $137 m | $137 m | $137 m |
| CDC – Infectious Diseases and Opioid Epidemic | $13 m | $18 m | $23 m | $23 m | $23 m |
| CDC – Ending the HIV Epidemic | $175 m | $195 m | $220 m | $220 m | $220 m |
| CDC – Public Health Infrastructure and Capacity | N/A | $200 m | $350 m | $350 m | $350 m |
| HRSA – Ryan White – Total | $2.424 b | $2.495 b | $2.571 b | $2.571 b | $2.581 b |
| HRSA – Ryan White – Ending the HIV Epidemic | $105 m | $125 m | $165 m | $165 m | $175 m |
| HRSA – Community Health Centers | $5.7 b | $5.75 b | $5.86 b | $5.86 b | $8.2 b |
| HRSA – Community Health Centers – Ending the HIV Epidemic | $102.3 m | $122.3 m | $157 m | $157 m | $157 m |
| HRSA – Title X Family Planning Program | $286.5 m | $286.5 m | $286.5 m | $286.5 m | $390 m |
| HRSA – STI Clinical Services Demonstration Project | N/A | N/A | N/A | N/A | $0 |
| Teen Pregnancy Prevention Program (TPP) | $101 m | $101 m | $101 m | $101 m | $101 m |
| ACF – “Sexual Risk Avoidance” – Abstinence-Only Program | $35 m | $35 m | $35 m | $35 m | $0 |
| Secretary’s Minority AIDS Initiative (MIA) | $55.4 m | $56.9 m | $60 m | $60 m | $60 m |
| Housing for People Living with AIDS (HOPWA) | $430 m | $450 m | $499 m | $505 m | $505 m |
| NIH – Office of AIDS Research | $3.090 b | $3.194 b | $3.294 b | TBA (likely $3.294 b) | $3.294 b |
Text of the funding package is available here. The Labor, Health and Human Services, Education, and Related Agencies summary and statement can be found here: Bill Summary and Explanatory Statement. Additionally, the final agreement states that language in the Senate FY’24 LHHS report carries the same weigh as the explanatory statement, and that report can be found here.
For FY’25, we are facing strong headwinds in the form of spending caps, federal elections, and the continued politicization of public health and sexual health. To offset these challenges, NCSD has already begun working with our coalition partners, and meeting with Members of Congress and their staff to advocate for increased STI prevention and clinical services funding. We will keep you apprised of our progress as the year unfolds.
If you have questions, please reach out to Stephanie Arnold Pang (Senior Director, Policy and Government Relations) at [email protected] or Rachel Deitch (Director, Federal Policy) at [email protected].